These are the most recent
09/30/2021 BAKER BROS. ADVISORS, LP Director Buy 86,932 $95.83 8.3M 13,526,726
09/29/2021 BAKER BROS. ADVISORS, LP Director Disposition (Non Open Market) 16 $102.00 1.6K 13,439,794
09/29/2021 BAKER BROS. ADVISORS, LP Director Option Execute 149,999 $0.01 1.5K 13,439,808
09/20/2021 EHRLICH, JASON Officer Automatic Sell 6,950 $99.74 - $101.31 693.2K 51,541
09/20/2021 EHRLICH, JASON Officer Option Execute 6,950 $10.29 71.5K 58,491
09/16/2021 BAKER BROS. ADVISORS, LP Director Buy 1,153 $94.59 109.1K 13,300,993
09/15/2021 BAKER BROS. ADVISORS, LP Director Buy 30,685 $94.38 - $94.48 2.9M 13,299,840
09/07/2021 BAKER BROS. ADVISORS, LP Director Buy 57,501 $92.88 - $93.35 5.3M 13,269,155
Kiwi
Recent KOD News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:05:09 PM
- Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results • PR Newswire (US) • 08/14/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:52:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:48:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:00:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:39:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:11:00 PM
- Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences • PR Newswire (US) • 05/29/2024 08:36:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:10:18 PM
- Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results • PR Newswire (US) • 05/15/2024 08:01:00 PM
- Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy • PR Newswire (US) • 05/13/2024 11:32:00 PM
- Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform • PR Newswire (US) • 05/02/2024 08:30:00 PM
- Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/28/2024 10:30:00 AM
- Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024 • PR Newswire (US) • 03/26/2024 10:15:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:23:00 PM
- Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting • PR Newswire (US) • 01/30/2024 11:30:00 AM
- Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/04/2024 09:15:00 PM
- Kodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference • PR Newswire (US) • 11/21/2023 09:15:00 PM
- Kodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights • PR Newswire (US) • 11/14/2023 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 11:05:54 AM
- Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission • PR Newswire (US) • 11/06/2023 10:00:00 AM
- KODIAK SCIENCES ANNOUNCES FIRST TIME PRESENTATION OF PRIMARY ENDPOINT DATA FROM TARCOCIMAB TEDROMER PHASE 3 GLOW STUDY IN PATIENTS WITH DIABETIC RETINOPATHY AT AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING • PR Newswire (US) • 11/02/2023 03:21:00 AM
- Kodiak Sciences Announces Upcoming Presentations at the 56th Annual Scientific Meeting of the Retina Society • PR Newswire (US) • 10/11/2023 10:00:00 AM
- Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference • PR Newswire (US) • 09/08/2023 10:00:00 AM
- New one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion • PR Newswire (US) • 09/07/2023 10:00:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM